C | SK | CHEMISTRY; METALLURGY |
C12 | KL | BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING |
C12P | UKL | FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE [3] |
C12P 1/00 | HGR | Preparation of compounds or compositions, not provided for in groups C12P 3/00-C12P 39/00, by using microorganisms or enzymes; General processes for the preparation of compounds or compositions by using microorganisms or enzymes [3, 2006.01] |
C12P 1/02 | UGR1 | . | by using fungi [3, 2006.01] |
|
C12P 1/04 | UGR1 | . | by using bacteria [3, 2006.01] |
|
C12P 1/06 | UGR1 | . | by using actinomycetales [3, 2006.01] |
|
C12P 3/00 | HGR | Preparation of elements or inorganic compounds except carbon dioxide [3, 2006.01] |
C12P 5/00 | HGR | Preparation of hydrocarbons [3, 2006.01] |
C12P 5/02 | UGR1 | |
C12P 7/00 | HGR | Preparation of oxygen-containing organic compounds [3, 2006.01] |
C12P 7/02 | UGR1 | . | containing a hydroxy group [3, 2006.01] |
|
C12P 7/04 | UGR2 | |
C12P 7/06 | UGR3 | . . . | Ethanol, i.e. non-beverage [3, 2006.01] |
|
C12P 7/08 | UGR4 | . . . . | produced as by-product or from waste or cellulosic material substrate [3, 2006.01] |
|
C12P 7/10 | UGR5 | . . . . . | substrate containing cellulosic material [3, 2006.01] |
|
C12P 7/12 | UGR5 | . . . . . | substrate containing sulfite waste liquor or citrus waste [3, 2006.01] |
|
C12P 7/14 | UGR4 | . . . . | Multiple stages of fermentation; Multiple types of microorganisms or reuse for microorganisms [3, 2006.01] |
|
C12P 7/16 | UGR3 | . . . | Butanols [3, 2006.01] |
|
C12P 7/18 | UGR3 | . . . | polyhydric [3, 2006.01] |
|
C12P 7/20 | UGR4 | . . . . | Glycerol [3, 2006.01] |
|
C12P 7/22 | UGR2 | |
C12P 7/24 | UGR1 | . | containing a carbonyl group [3, 2006.01] |
|
C12P 7/26 | UGR2 | |
C12P 7/28 | UGR3 | . . . | Acetone-containing products [3, 2006.01] |
|
C12P 7/30 | UGR4 | . . . . | produced from substrate containing inorganic compounds other than water [3, 2006.01] |
|
C12P 7/32 | UGR4 | . . . . | produced from substrate containing inorganic nitrogen source [3, 2006.01] |
|
C12P 7/34 | UGR4 | . . . . | produced from substrate containing protein as nitrogen source [3, 2006.01] |
|
C12P 7/36 | UGR4 | . . . . | produced from substrate containing grain or cereal material [3, 2006.01] |
|
C12P 7/38 | UGR3 | . . . | Cyclopentanone- or cyclopentadione- containing products [3, 2006.01] |
|
C12P 7/40 | UGR1 | . | containing a carboxyl group [3, 2006.01] |
|
C12P 7/42 | UGR2 | . . | Hydroxy carboxylic acids [3, 2006.01] |
|
C12P 7/44 | UGR2 | . . | Polycarboxylic acids [3, 2006.01] |
|
C12P 7/46 | UGR3 | . . . | Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid [3, 2006.01] |
|
C12P 7/48 | UGR3 | . . . | Tricarboxylic acids, e.g. citric acid [3, 2006.01] |
|
C12P 7/50 | UGR3 | . . . | having keto groups, e.g. 2-ketoglutaric acid [3, 2006.01] |
|
C12P 7/52 | UGR2 | . . | Propionic acid; Butyric acids [3, 2006.01] |
|
C12P 7/54 | UGR2 | . . | Acetic acid [3, 2006.01] |
|
C12P 7/56 | UGR2 | . . | Lactic acid [3, 2006.01] |
|
C12P 7/58 | UGR2 | . . | Aldonic, ketoaldonic or saccharic acids (uronic acids C12P 19/00) [3, 2006.01] |
|
C12P 7/60 | UGR3 | . . . | 2-Ketogulonic acid [3, 2006.01] |
|
C12P 7/62 | UGR1 | . | Carboxylic acid esters [3, 2006.01] |
|
C12P 7/64 | UGR1 | . | Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats [3, 2006.01] |
|
C12P 7/66 | UGR1 | . | containing the quinoid structure [3, 2006.01] |
|
C12P 9/00 | HGR | Preparation of organic compounds containing a metal or atom other than H, N, C, O, S, or halogen [3, 2006.01] |
C12P 11/00 | HGR | Preparation of sulfur-containing organic compounds [3, 2006.01] |
C12P 13/00 | HGR | Preparation of nitrogen-containing organic compounds [3, 2006.01] |
C12P 13/02 | UGR1 | . | Amides, e.g. chloramphenicol [3, 2006.01] |
|
C12P 13/04 | UGR1 | . | Alpha- or beta-amino acids [3, 2006.01] |
|
C12P 13/06 | UGR2 | . . | Alanine; Leucine; Isoleucine; Serine; Homoserine [3, 2006.01] |
|
C12P 13/08 | UGR2 | . . | Lysine; Diaminopimelic acid; Threonine; Valine [3, 2006.01] |
|
C12P 13/10 | UGR2 | . . | Citrulline; Arginine; Ornithine [3, 2006.01] |
|
C12P 13/12 | UGR2 | . . | Methionine; Cysteine; Cystine [3, 2006.01] |
|
C12P 13/14 | UGR2 | . . | Glutamic acid; Glutamine [3, 2006.01] |
|
C12P 13/16 | UGR3 | . . . | using surfactants, fatty acids or fatty acid esters, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group or a carboxyl ester group [3, 2006.01] |
|
C12P 13/18 | UGR3 | . . . | using biotin or its derivatives [3, 2006.01] |
|
C12P 13/20 | UGR2 | . . | Aspartic acid; Asparagine [3, 2006.01] |
|
C12P 13/22 | UGR2 | . . | Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine [3, 2006.01] |
|
C12P 13/24 | UGR2 | . . | Proline; Hydroxyproline; Histidine [3, 2006.01] |
|
C12P 15/00 | HGR | Preparation of compounds containing at least three condensed carbocyclic rings [3, 2006.01] |
C12P 17/00 | HGR | Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms (C12P 13/04-C12P 13/24 take precedence) [3, 2006.01] |
C12P 17/02 | UGR1 | . | Oxygen as only ring hetero atoms [3, 2006.01] |
|
C12P 17/04 | UGR2 | . . | containing a five-membered hetero ring, e.g. griseofulvin [3, 2006.01] |
|
C12P 17/06 | UGR2 | . . | containing a six-membered hetero ring, e.g. fluorescein [3, 2006.01] |
|
C12P 17/08 | UGR2 | . . | containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons [3, 2006.01] |
|
C12P 17/10 | UGR1 | . | Nitrogen as only ring hetero atom [3, 2006.01] |
|
C12P 17/12 | UGR2 | . . | containing a six-membered hetero ring [3, 2006.01] |
|
C12P 17/14 | UGR1 | . | Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring [3, 2006.01] |
|
C12P 17/16 | UGR1 | . | containing two or more hetero rings [3, 2006.01] |
|
C12P 17/18 | UGR1 | . | containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin [3, 2006.01] |
|
C12P 19/00 | HGR | Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P 7/58) [3, 2006.01] |
C12P 19/02 | UGR1 | . | Monosaccharides [3, 2006.01] |
|
C12P 19/04 | UGR1 | . | Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds [3, 2006.01] |
|
C12P 19/06 | UGR2 | . . | Xanthan, i.e. Xanthomonas-type heteropolysaccharides [3, 2006.01] |
|
C12P 19/08 | UGR2 | |
C12P 19/10 | UGR2 | |
C12P 19/12 | UGR1 | . | Disaccharides [3, 2006.01] |
|
C12P 19/14 | UGR1 | . | produced by the action of a carbohydrase, e.g. by alpha-amylase [3, 2006.01] |
|
C12P 19/16 | UGR1 | . | produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin [3, 2006.01] |
|
C12P 19/18 | UGR1 | . | produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins [3, 2006.01] |
|
C12P 19/20 | UGR1 | . | produced by the action of an exo-1, 4 alpha-glucosidase, e.g. dextrose [3, 2006.01] |
|
C12P 19/22 | UGR1 | . | produced by the action of a beta-amylase, e.g. maltose [3, 2006.01] |
|
C12P 19/24 | UGR1 | . | produced by the action of an isomerase, e.g. fructose [3, 2006.01] |
|
C12P 19/26 | UGR1 | . | Preparation of nitrogen-containing carbohydrates [3, 2006.01] |
|
C12P 19/28 | UGR2 | . . | N-glycosides [3, 2006.01] |
|
C12P 19/30 | UGR3 | . . . | Nucleotides [3, 2006.01] |
|
C12P 19/32 | UGR4 | . . . . | having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same-ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide [3, 2006.01] |
|
C12P 19/34 | UGR4 | . . . . | Polynucleotides, e.g. nucleic acids, oligoribonucleotides [3, 2006.01] |
|
C12P 19/36 | UGR4 | . . . . | Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate [3, 2006.01] |
|
C12P 19/38 | UGR3 | . . . | Nucleosides [3, 2006.01] |
|
C12P 19/40 | UGR4 | . . . . | having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides [3, 2006.01] |
|
C12P 19/42 | UGR3 | . . . | Cobalamins, i.e. vitamin B12, LLD factor [3, 2006.01] |
|
C12P 19/44 | UGR1 | . | Preparation of O-glycosides, e.g. glucosides [3, 2006.01] |
|
C12P 19/46 | UGR2 | . . | having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin [3, 2006.01] |
|
C12P 19/48 | UGR3 | . . . | the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin [3, 2006.01] |
|
C12P 19/50 | UGR4 | . . . . | having two saccharide radicals bound through only oxygen to adjacent ring carbon atoms of the cyclohexyl radical, e.g. ambutyrosin, ribostamycin [3, 2006.01] |
|
C12P 19/52 | UGR5 | . . . . . | containing three or more saccharide radicals, e.g. neomycin, lividomycin [3, 2006.01] |
|
C12P 19/54 | UGR3 | . . . | the cyclohexyl radical being bound directly to a nitrogen atom of two or more radicals, e.g. streptomycin [3, 2006.01] |
|
C12P 19/56 | UGR2 | . . | having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin [3, 2006.01] |
|
C12P 19/58 | UGR2 | . . | having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin [3, 2006.01] |
|
C12P 19/60 | UGR2 | . . | having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin [3, 2006.01] |
|
C12P 19/62 | UGR3 | . . . | the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin [3, 2006.01] |
|
C12P 19/64 | UGR1 | . | Preparation of S-glycosides, e.g. lincomycin [3, 2006.01] |
|
C12P 21/00 | HGR | Preparation of peptides or proteins (single-cell protein C12N 1/00) [3, 2006.01] |
C12P 21/02 | UGR1 | . | having a known sequence of two or more amino acids, e.g. glutathione [3, 2006.01] |
|
C12P 21/04 | UGR2 | . . | Cyclic or bridged peptides or polypeptides, e.g. bacitracin (cyclised by āSāSā bonds only C12P 21/02) [3, 2006.01] |
|
C12P 21/06 | UGR1 | . | produced by the hydrolysis of a peptide bond, e.g. hydrolysate products [3, 2006.01] |
|
C12P 21/08 | UGR1 | . | Monoclonal antibodies [5, 2006.01] |
|
C12P 23/00 | HGR | Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing hetero-rings C12P 17/00) [3, 2006.01] |
C12P 25/00 | HGR | Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin [3, 2006.01] |
C12P 27/00 | HGR | Preparation of compounds containing a gibbane ring system, e.g. gibberellin [3, 2006.01] |
C12P 29/00 | HGR | Preparation of compounds containing a naphthacene ring system, e.g. tetracycline (C12P 19/00 takes precedence) [3, 2006.01] |
C12P 31/00 | HGR | Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins [3, 2006.01] |
C12P 33/00 | HGR | Preparation of steroids [3, 2006.01] |
C12P 33/02 | UGR1 | . | Dehydrogenating; Dehydroxylating [3, 2006.01] |
|
C12P 33/04 | UGR2 | . . | Forming an aryl ring from A ring [3, 2006.01] |
|
C12P 33/06 | UGR1 | . | Hydroxylating [3, 2006.01] |
|
C12P 33/08 | UGR2 | . . | at 11 position [3, 2006.01] |
|
C12P 33/10 | UGR3 | . . . | at 11alpha-position [3, 2006.01] |
|
C12P 33/12 | UGR1 | . | Acting on D ring [3, 2006.01] |
|
C12P 33/14 | UGR2 | . . | Hydroxylating at 16 position [3, 2006.01] |
|
C12P 33/16 | UGR2 | . . | Acting at 17 position [3, 2006.01] |
|
C12P 33/18 | UGR3 | . . . | Hydroxylating at 17 position [3, 2006.01] |
|
C12P 33/20 | UGR1 | . | containing heterocyclic rings [3, 2006.01] |
|
C12P 35/00 | HGR | Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin [3, 2006.01] |
C12P 35/02 | UGR1 | . | by desacylation of the substituent in the 7 position [3, 2006.01] |
|
C12P 35/04 | UGR1 | . | by acylation of the substituent in the 7 position [3, 2006.01] |
|
C12P 35/06 | UGR1 | . | Cephalosporin C; Derivatives thereof [3, 2006.01] |
|
C12P 35/08 | UGR1 | . | disubstituted in the 7 position [3, 2006.01] |
|
C12P 37/00 | HGR | Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin [3, 2006.01] |
C12P 37/02 | UGR1 | . | in presence of phenylacetic acid or phenylacetamide or their derivatives [3, 2006.01] |
|
C12P 37/04 | UGR1 | . | by acylation of the substituent in the 6 position [3, 2006.01] |
|
C12P 37/06 | UGR1 | . | by desacylation of the substituent in the 6 position [3, 2006.01] |
|
C12P 39/00 | HGR | Processes involving microorganisms of different genera in the same process, simultaneously [3, 2006.01] |
C12P 41/00 | HGR | Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture [4, 2006.01] |